About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 20 record(s)
Nothing to report this month
Organization: Patented Medicine Prices Review Board Canada
Req # A-2022-00075
Obtain a complete copy of the analyses, studies or research, evaluations/reviews to measure the performance/productivity of your employees/public servants who have been teleworking since the beginning of the pandemic between March 1, 2020, and today, September 5, 2022.Organization: Canada Post
January 2023
Req # A-2022-00078
A copy of the most recent cost estimate for Canada Post in the event of the death of Queen Elizabeth II. A copy of documents detailing the costs associated with stamp changes that occurred between September 13, 2012, and September 13, 2022, following the death of the Queen. A copy of the notes regarding the death of Queen Elizabeth II provided to the president of Canada Post, and the minister responsible for Canada Post, between September 8 and September 13, 2022.Organization: Canada Post
January 2023
Req # A-2022-00081
Copy of documents showing the number of tax packages for 2016 sent by the Canada Revenue Agency to the Anjou post office, 7100 rue Jarry Est, Montreal, Quebec H1J 1G0, between January 1, 2017, and April 30, 2017.Organization: Canada Post
January 2023
Req # A-2022-09060
Recordings or transcripts of both of the French language webinars given by the PMPRB on November 8th, 2022, including any audience questions and the PMPRB's responses. Copies of the English and French PowerPoint for the industry specific webinars held on November 8th, 2022.Organization: Patented Medicine Prices Review Board Canada
January 2023
Req # A-2022-09061
Copy of the resignation letter of the Vice-Chair Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
January 2023
Req # A-2021-10762
Provide all emails, preparation documents, and similar materials that Douglas Clark and other PMPRB executives sent or received related to the recent statement given to the Hill Times for their May 25th article. Include, but do not limit the scope of the request to, emails related to the drafting of the statement.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-10767
Copies of all briefing material provided to Douglas Clark from May 22, 2021 to June 11, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24151
All data source files used to produce the CompassRx 7th Edition Annual Public Drug Plan Expenditure Report, 2019/20, published November 2021 and available here:https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/compassrx-7th-edition.html and here:https://www.canada.ca/content/dam/pmprb-cepmb/documents/npduis/analytical-studies/compassrx-7th-edition/NPDUIS-CompassRx7th-2019-2020_en.pdf.Organization: Patented Medicine Prices Review Board Canada
January 2022
Req # A-2021-24939
Copies of the preparation documents, meeting summaries and emails related to the weekly meetings between Douglas Clark and Mitchell Levine from May 1, 2021 to December 20, 2021.Organization: Patented Medicine Prices Review Board Canada
January 2022